All In Biotech

Drug Trial Radar · NCT05593029

A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder

Last checked: Nov 20, 2026Latest source record: Feb 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 929 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

929

Actual

Start

Nov 9, 2022

Primary completion

Nov 6, 2025

Study completion Nov 13, 2025

Sponsor

Sponsor type
Industry
First posted
Oct 25, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Demonstrate ability of SEP-363856 to be superior to placebo as an adjunctive therapy to ADT in change from baseline in depressive symptoms (MADRS \& CGI-S) in MDD patients who had an inadequate response to prior ADT therapy.

Conditions

  • Major Depressive Disorder

Interventions

  • SEP-363856Drug

    Tablet

  • PlaceboOther

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Montgomery Åsberg Depression Rating Scale (MADRS)Time frame: From baseline to week 14

Locations

77 sites in 7 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Scottsdale Clinical Research

    Scottsdale, Arizona

  • DelSol Research

    Tucson, Arizona

  • Pillar Clinical Research

    Bentonville, Arkansas

  • ProScience Research Group

    Culver City, California

  • Wr-Pri, Llc

    Encino, California

  • Collaborative NeuroScience Research , LLC

    Garden Grove, California

  • Alliance Research

    Long Beach, California

  • ATP Clinical Research, Inc.

    Orange, California

  • Anderson Clinical Research

    Redlands, California

  • California Mental Behavioral Health

    Santee, California

  • Schuster Medical Research Institute SMRI

    Sherman Oaks, California

  • Viking Clinical Research

    Temecula, California

  • Collaborative Neuroscience Research LLC

    Torrance, California

  • Sunwise Clinical Research with is in Lafayette, CA

    Walnut Creek, California

  • Institute of Living Hartford Hospital

    Hartford, Connecticut

  • Clinical Neuroscience Solutions Inc.

    Jacksonville, Florida

  • K2 Medical Research

    Maitland, Florida

  • Central Miami Medical Institute

    Miami, Florida

  • Clinical Neuroscience Solutions Inc. dba CNS Healthcare

    Orlando, Florida

  • Combined Research Orlando Phase I-IV

    Orlando, Florida

  • K2 Medical Research

    Tampa, Florida

  • Interventional Psychiatry of Tampa Bay

    Tampa, Florida

  • Advanced Discovery Research LLC

    Atlanta, Georgia

  • Renew Health Clinical Research

    Snellville, Georgia

  • MetroMed Clinical Trials

    Chicago, Illinois

  • AMR Convention Research

    Warrenville, Illinois

  • Benchmark Research

    Shreveport, Louisiana

  • Cenexel CBH (CBH Health)

    Gaithersburg, Maryland

  • Copley Clinical

    Boston, Massachusetts

  • Boston Clinical Trials

    Roslindale, Massachusetts

  • Adams Clinical

    Watertown, Massachusetts

  • Vitalix Clinical

    Worcester, Massachusetts

  • Neurobehavioral Medicine Group

    Bloomfield Hills, Michigan

  • Precise Research Centers

    Flowood, Mississippi

  • Center for Emotional Fitness

    Cherry Hill, New Jersey

  • Integrative Clinical Trials

    Brooklyn, New York

  • Basil Clinical

    Inwood, New York

  • Berman Clinical

    New York, New York

  • Manhattan Behavioral Medicine PLLC

    New York, New York

Showing 40 of 77 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.